News and Announcements
Anteo Signs Licensing Agreement with Leading Life Science Company
- Published March 13, 2012 11:41AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
13 March 2012: Anteo Diagnostics Limited (ASX:ADO) is pleased to announce that it has signed a Patent and Technoology License Agreement with eBioesence, a leading US headquartered Life Sciences Company, providing with access to Anteo’s unique Mix&Go technology.
Under the terms of the Agreement, Anteo will supply Mix&Go for the use in the manufacture of biological reagents for all the applicable markets in which the company operates. Anteo will receive an initial upfront payment, fixed revenue for Mix&Go reagent supplied, and a royalty fee paid quarterly based on a percentage of worldwide net sales.
——
To view the full article, please click here.